How Your Liver Processes a New Injection Medicine
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests how your body processes a new medicine called HRS9531 when injected. Researchers want to understand how liver function affects the medicine's breakdown, which helps them determine safe doses for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 65 years old
- Weigh at least 50 kg (men) or 45 kg (women), with a healthy BMI
- Not be pregnant, planning pregnancy, or breastfeeding during the study and for 2 months after your last dose
- Not have participated in another drug trial within the past 3 months
- Be willing to avoid smoking, alcohol, and recreational drugs during the study
- Not have had major surgery in the past 6 months or planned during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how a new medicine (SHR-3167) is absorbed by the body and checks for side effects. Healthy volunteers ages 18-55 can join to help researchers understand how this drug works.
This trial is testing how different ways of taking an oral medication (HRS9531) affect the drug levels in the body. It is for healthy men to help find the best dosing conditions for future studies.
This early-phase trial tests the safety and tolerability of a new injection called HRS-5817 in healthy volunteers. It helps researchers understand how the drug moves through the body and what side effects it might have.
This trial tests an investigational injection called HRS-4729 for weight loss in people with obesity. It checks if the drug is safe and effective when used along with diet and exercise.
This study tests whether a new injectable medication called HRS9531 is safe and well-tolerated in teenagers aged 12–17 with obesity. Researchers will monitor how your body handles the medication and whether it affects your weight.
This trial tests a new injection called SYH2092 in healthy adults, not for treating a disease. Participation helps researchers understand how the drug works in the body and if it is safe. If you qualify, you may be compensated for your time.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.